Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$222,699
+$110,105 QoQ
Shares Held
1,421
+40.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,271
of 1,603 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,699 | 1,421 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $112,594 | 1,010 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $99,353 | 1,021 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $106,508 | 926 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $110,186 | 1,035 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $101,179 | 1,046 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $739,504 | 7,324 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $837,696 | 8,224 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $853,194 | 8,455 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $713,736 | 7,758 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $705,983 | 7,782 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $622,673 | 8,192 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $703,881 | 8,327 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $332,835 | 3,793 | Shares | Sole | 2023-12-13 | |
| No filing history on record for this holder in this stock. | ||||||